Bayer sued over health claims about multivitamin for men

The Washington, D.C.-based Center for Science in the Public Interest (CSPI), a nonprofit health advocacy group, is suing German drug giant Bayer for allegedly providing misleading information by claiming that selenium in its Men's One A Day multivitamin might reduce the risk of prostate cancer.